Feb. 24, 2014 -- Rick Andrew, Director of NSF International's Drinking Water Business Development Division, will discuss a new draft standard on emerging compounds/incidental contaminants at Aquatech USA, the Water Quality Association's (WQA) annual convention and exposition, in Orlando, Fla., on Thursday, March 20, at 8:00 am. The session is open to all registered attendees.
NSF 401 Drinking water treatment units - Emerging Compounds/Incidental Contaminants establishes requirements designed to reduce emerging compounds, including pharmaceuticals, personal care products, chemicals, and endocrine-disrupting compounds such as Bisphenol A (BPA) in water. Products covered in the standard include several types of drinking water treatment products such as mouth-drawn and hand-squeezed, sports-bottle-type filtration systems, point-of-use reverse osmosis (RO) systems and traditional filtration systems.
This standard will focus on claims being made for the reduction of 15 individual compounds including BPA, Meprobamate, Phenytoin, Atenolol, Carbamazepine, TCEP, TCPP, DEET, Metolachlor, Trimethoprim, Ibuprofen, Naproxen, Estrone, Linuron, and Nonyl phenol. This list of contaminants represents compounds that have been identified in published studies as occurring in drinking water, and the claims are based on testing the actual compound in question.
See also: "Managing Micro-pollutants"
WQA Aquatech USA, the Water Quality Association's annual convention and exposition, attracts multiple water industry groups including process, drinking water, and ultrapure for residential, commercial and industrial users. WQA Aquatech USA is a one-stop event that connects technologies, know-how, education, training, networking and business opportunities to multiple water industries. It's where your industry and your association brings together, in one place, essential people, new ideas and innovative technology. For more information, visit www.wqa-aquatech.com.